Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease o...
Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Sclerostin inhibitors protect against osteoporotic fractures, but their cardiovascular safety remains unclear. We conducted a
cis
-Mendelian randomisation analysis to estimate the causal effect of sclerostin levels on cardiovascular risk factors. We meta-analysed three GWAS of sclerostin levels including 49,568 Europeans and selected 2 SNPs t...
Alternative Titles
Full title
Effect of genetically predicted sclerostin on cardiovascular biomarkers, risk factors, and disease outcomes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4350d228ebd54f46aff3945119c4aa78
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4350d228ebd54f46aff3945119c4aa78
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-024-53623-5
